stocktwits.com/symbol/HTBX
Anzeige
Meldung des Tages: 9 von 13 Treffern in den ersten 25 Metern: Wird das der Gamechanger für diese Goldaktie?
Neuester,
zuletzt geles. Beitrag
Antworten | Hot-Stocks-Forum Übersicht
Zurück
Weiter
... 147 148 150 151 ...
Antworten | Hot-Stocks-Forum Übersicht
Zurück
Weiter ... 147 148 150 151 ...
Heat Biologics - 3 Krebsmittel in der Pipeline!
Beiträge:
4.382
Zugriffe: 1.410.598 / Heute: 166
Zugriffe: 1.410.598 / Heute: 166
|
Werbung
Entdecke die beliebtesten ETFs von Amundi
Lyxor Net Zero 2050 S&P World Climate PAB (DR) UCITS ETF Acc
Perf. 12M: +206,18%
Amundi IBEX 35 Doble Apalancado Diario (2x) UCITS ETF Acc
Perf. 12M: +111,98%
Amundi MSCI Greece UCITS ETF Dist
Perf. 12M: +63,46%
Amundi MSCI Emerging Markets Swap II UCITS ETF USD Acc
Perf. 12M: +53,53%
Amundi Global Hydrogen UCITS ETF - Acc
Perf. 12M: +51,54%
WEEEE old.nasdaq.com/symbol/htbx/real-time
old.nasdaq.com/symbol/htbx/real-time
The company also recently joined the Alliance for Biosecurity, which may help it “secure government funding to support its rapid development, production, and distribution” of its COVID-19 vaccine, according to Maxim Group analysts.
www.marketwatch.com/story/...and-2020-03-06?mod=mw_quote_news
www.marketwatch.com/story/...and-2020-03-06?mod=mw_quote_news
www.stockscores.com/charts/charts/?ticker=Htbx
stockcharts.com/h-sc/ui?s=Htbx
stockcharts.com/h-sc/ui?s=Htbx
Institutional Investors increase holdings - Morgan Stanley stands out big increase
www.marketbeat.com/stocks/NASDAQ/HTBX/institutional-ownership/
www.marketbeat.com/stocks/NASDAQ/HTBX/institutional-ownership/
HTBX Need To Know: Analysts Are Much More Bullish On Heat Biologics, Inc. (NASDAQ:HTBX) Revenues
Simply Wall St
6 mins ago
Heat Biologics, Inc. (NASDAQ:HTBX) shareholders will have a reason to smile today, with the analysts making substantial upgrades to this year’s forecasts. The revenue forecast for this year has experienced a facelift, with analysts now much more optimistic on its sales pipeline. Investors have been pretty optimistic on Heat Biologics too, with the stock up 33% to US$0.77 over the past week. It will be interesting to see if today’s upgrade is enough to propel the stock even higher.
Following the upgrade, the consensus from four analysts covering Heat Biologics is for revenues of US$1.7m in 2020, implying a stressful 49% decline in sales compared to the last 12 months. Losses are predicted to fall substantially, shrinking 35% to US$0.34. Yet prior to the latest estimates, the analysts had been forecasting revenues of US$933k and losses of US$0.35 per share in 2020. So there’s been quite a change-up of views after the recent consensus updates, with the analysts making a sizeable increase to their revenue forecasts while also reducing the estimated loss as the business grows towards breakeven.
simplywall.st/stocks/us/...ogics-inc-nasdaqhtbx-revenues/amp/
Simply Wall St
6 mins ago
Heat Biologics, Inc. (NASDAQ:HTBX) shareholders will have a reason to smile today, with the analysts making substantial upgrades to this year’s forecasts. The revenue forecast for this year has experienced a facelift, with analysts now much more optimistic on its sales pipeline. Investors have been pretty optimistic on Heat Biologics too, with the stock up 33% to US$0.77 over the past week. It will be interesting to see if today’s upgrade is enough to propel the stock even higher.
Following the upgrade, the consensus from four analysts covering Heat Biologics is for revenues of US$1.7m in 2020, implying a stressful 49% decline in sales compared to the last 12 months. Losses are predicted to fall substantially, shrinking 35% to US$0.34. Yet prior to the latest estimates, the analysts had been forecasting revenues of US$933k and losses of US$0.35 per share in 2020. So there’s been quite a change-up of views after the recent consensus updates, with the analysts making a sizeable increase to their revenue forecasts while also reducing the estimated loss as the business grows towards breakeven.
simplywall.st/stocks/us/...ogics-inc-nasdaqhtbx-revenues/amp/
UPTRENDCHART !!!
stockscores.com/charts/char...
stockcharts.com/h-sc/ui?s=Htbx
stockscores.com/charts/char...
stockcharts.com/h-sc/ui?s=Htbx
old.nasdaq.com/symbol/htbx/real-time
patft.uspto.gov/netacgi/...&f=G&l=50&s1=10,660,936
JA!!!!!!!!!!!!
Gruß vom
Advamillionär
Gruß vom
Advamillionär
kommen , da aber keiner weiß wann News und Informationen veröffentlicht werden von der Firma kann es auch passieren dass wir diese Woche nichts von der Firma hören und es gibt immer ein paar ungeduldige oder es gibt immer ein paar die nur ein oder zwei Tage in diese Aktie drin sind und dann haben wir eine Konsolidierungsphase zwischen 90 Cent und ein Donner zählen und werden pendeln pendeln pendeln bis endlich News oder Informationen über dem weitere Zukunft der Firma kommen aber ich spekuliere auf gute Zukunft
Aber wie immer gilt das ist keine Kaufempfehlung und keine Verkauf Empfehlung von mir jeder muss selbst handeln und sich informieren und muss selbst auf den Knopf drücken
Aber wie immer gilt das ist keine Kaufempfehlung und keine Verkauf Empfehlung von mir jeder muss selbst handeln und sich informieren und muss selbst auf den Knopf drücken
Es gibt keine neuen Beiträge.
|
Neueste Beiträge aus dem Scorpius Forum
| Wertung | Antworten | Thema | Verfasser | letzter Verfasser | letzter Beitrag | |
8 | 4.381 | Heat Biologics - 3 Krebsmittel in der Pipeline! | Balu4u | centsucher | 03.08.25 23:10 | |
| 2 | Face the Heat | VEB Plaste und Ela. | Advamillionär | 24.04.21 23:58 |